These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21098579)

  • 1. Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure.
    Galasso G; De Rosa R; Piscione F; Iaccarino G; Vosa C; Sorriento D; Piccolo R; Rapacciuolo A; Walsh K; Chiariello M
    Eur J Heart Fail; 2010 Dec; 12(12):1290-6. PubMed ID: 21098579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
    Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
    J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
    Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
    J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo.
    Bonifacio A; Mullen PJ; Mityko IS; Navegantes LC; Bouitbir J; Krähenbühl S
    Arch Toxicol; 2016 Jan; 90(1):203-15. PubMed ID: 25300705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
    Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
    Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
    Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
    Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle.
    Louis E; Raue U; Yang Y; Jemiolo B; Trappe S
    J Appl Physiol (1985); 2007 Nov; 103(5):1744-51. PubMed ID: 17823296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells.
    Clavel S; Siffroi-Fernandez S; Coldefy AS; Boulukos K; Pisani DF; Dérijard B
    Mol Cell Biol; 2010 Jan; 30(2):470-80. PubMed ID: 19917721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
    Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
    Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fasting and refeeding on expression of atrogin-1 and Akt/FOXO signaling pathway in skeletal muscle of chicks.
    Nakashima K; Yakabe Y; Yamazaki M; Abe H
    Biosci Biotechnol Biochem; 2006 Nov; 70(11):2775-8. PubMed ID: 17090921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation.
    Xie P; Guo S; Fan Y; Zhang H; Gu D; Li H
    J Biol Chem; 2009 Feb; 284(9):5488-96. PubMed ID: 19117950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway.
    Halon-Golabek M; Borkowska A; Kaczor JJ; Ziolkowski W; Flis DJ; Knap N; Kasperuk K; Antosiewicz J
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):557-569. PubMed ID: 29380557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxo/atrogin induction in human and experimental myositis.
    Lee HK; Rocnik E; Fu Q; Kwon B; Zeng L; Walsh K; Querfurth H
    Neurobiol Dis; 2012 May; 46(2):463-75. PubMed ID: 22590725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.
    Pöllänen E; Ronkainen PH; Horttanainen M; Takala T; Puolakka J; Suominen H; Sipilä S; Kovanen V
    Growth Horm IGF Res; 2010 Oct; 20(5):372-9. PubMed ID: 20724185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
    Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
    Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress.
    Chaanine AH; Kohlbrenner E; Gamb SI; Guenzel AJ; Klaus K; Fayyaz AU; Nair KS; Hajjar RJ; Redfield MM
    Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1540-H1559. PubMed ID: 27694219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.